Objective: to review the published papers reportingonthe use of infrainguinal angioplasty in the treatment of critical limb ischaemia(cli).
IntroDUCtIon
Reduced arterial blood flow in al imb causing rest pain or tissue loss (ulceration or gangrene) represents critical limb ischaemia (CLI). CLI, with or without diabetes mellitus, accounts for 70-90% of lower limb amputations (1, 2) and is ag rowing problem in an ageing population demanding increasing vascular surgical resources (3). In 10-40% of cases CLI leads to primary amputation (4, 5). As the outcome of CLI is so poor,t he European Consensus Document recommended revascularisation for the treatment of CLI if therei sm oret han a2 5% chance of patient survival and limb salvage for one year (6). Whether the mode of revascularisation should be percutaneous transluminal angioplasty( PtA), subintimal angioplasty (SAP) or surgery is an issue of increasing interest but also asource of controversy (7, 8) . the same patients may receive entirely different treatment depending on which hospital they attend (7) . the fast evolution of endovascular techniquesm akes the evaluation of their pros and cons amoving target.
Majorityofpatients with CLI have amultisegmental disease (9,10) and an increasing proportiona re diabetics whose arterial disease primarily affects the infrapopliteal arteries (11) . therefore, the effectiveness of angioplasty below the inguinal ligament is the main issue in the evaluation of endovascular treatment of CLI.
Proper randomised controlled trials requirealarge number of patients with easily definable inclusion criteria. the major problem related to lower limb occlusive changes is the multitude of anatomic varieties andthereforepoor comparability,whichisillustrated by the attempts to classify lower extremity arterial disease summarised in the trans Atlantic Consensus Document (tASC) (12) . the BASIL trial is so far the largest randomised trial on the current subject (13) .
the aim of this review is to analyse the literature regarding the role of PtAorSAP in treatingCLI patients.
MEtHoDS
As earch of MEDLInE and the Cochrane Library was performed to identify articles relating to the issue.Search terms included "angioplasty", "peripheral vascular disease" and "criticall imb ischaemia". only papers in which the authors reported separately the results of infrainguinal angioplasty in non-claudicants wereincluded. Highest priority was given to randomised controlled trials. rESULtS SIngLE CEntrE DAtA the results of PtAintreating critical limb ischaemia during the 1980s and 1990s werem ainly fairly poor (9). Limb salvage rates for the patients treated varied from 50% at 5months (14) to 56% at one year (15) . recent papers reporting on the results of infrainguinalangioplasty as treatment for CLI patientsshow excellent limb salvage rates of up to 91% at 5y ears (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (table 1) . Interestingly,many studies reported high limb salvage and clinical improvement rates (72-89% in 2-3 years), regardless of the patency rates (16, 18, 25, 26, 29) (table 2) . the patency and leg salvage gap was significantly higher in the group of endovascular series as compared to the group of surgical series (p =0.001) (table 2). these studies provide only level V(scale I-V) scientific evidence as no controls of the treatment werei ncludedi nt hesec ase series (30) .
thereare centres with apolicy of treating majority of CLI patientswith subintimal angioplasty,based on their understanding that the results could be superior to surgery (25, 26) . Especially in the early phase therew as, however,c riticisms brought against the outstandingr esults from the Leicester group (9), mainly in terms of patient selection as other studies wereable to show only poor long-term patencyrates with subintimal angioplasty (29, 31, 32) . now there are also supportive data from other centres to confirm the good results of the Leicestergroup in treating CLI with subintimal angioplasty (33, 34) . Similarly,r ela- PoPULAtIon BASED DAtA thereare two nation-wide studiescomparing the results of surgery versus PtAint reating CLI patients (36, 37) . From Sweden, in 1998 Zdanowski and coworkers (37) reported that the outcome of these two treatmentmodalities was similar regarding both survival and amputation. the study from Finland in 2000 by Luther and colleagues favoured, in contrast, infrapopliteal bypass operations. this study showed asignificant inverse correlation only between the incidence of infrapopliteal surgical reconstructions and the incidence of below-knee amputations (36) . Both studies werepopulation-based and thus with patient groups that wereb yn om eans comparable giving level IV scientific evidence (30) .
CoCHrAnE rEVIEWS
the CochraneD atabaseo fs ystematic reviewsh as accepted two prospective randomised trials comparing bypass operations and PtAamong CLI patients (38, 39) . these ratherold studies included 61 and 72 patients with CLI as well as 41 and 191 claudicants, respectively (38, 39) . Both studies included only iliac and femoro-popliteal lesions. Pooling both trials showed no overall significant difference in amputation rates between the surgery and PtAgroups (or 1.48, 95% CI 0.79, 2.77) within the CLI group. this finding must, however,beviewed with caution, as no infrapopliteal lesions werei ncluded in these two studies. thusthesetrials represented only asubset of patients with CLI giving level II evidence on the comparability of angioplasty and surgery in treating lesions above popliteal bifurcation in patients with CLI (30) .
tHE BASIL trIAL
Amulticentre, randomised controlled trial, the BASIL (Bypass versus Angioplasty in SevereI schaemia of the Leg) trial from the United Kingdom( UK) compares the outcome of ab ypass-surgery-firsts trategy with ab alloon-angioplasty-first strategy in patients presenting with severelimb ischaemia due to infrainguinal disease (13) . the BASIL-trial ran for 5.5 years in 27 UK hospitals. 452 patients werer andomly assigned to receive asurgery-first (n =228) or an angioplasty-first (n =224) strategy.T he primary endpoint was amputation (of trial leg) free survival. During a6 -month BASIL audit in the top six recruitingcentres it was reported that 48% (n =220) of patients with with infrainguinal disease weretreated without revascularisation and 52% (n =236) underwent revascularisation. of these 236 potentially eligible patients, 70 (29%) wereregarded as suitable for randomisation into the BASIL trial.
the audit of the BASIL trial showed that 48% of the patients presenting with severelimb ischaemia to major UK vascular units and undergoing diagnostic imaging werer egarded as unsuitable or unfit for any form of revascularisation, whereas anational survey in 1993 in UK showed that nearly 70% of patients presenting with CLI wereoffered some form of revascularisation as primary treatment (40) . this may in- dicate some selectionb ias within the studyr ather than true decrease in revascularisation activity.
In the short-term (30 days), asurgery-first strategy was associated with as ignificantly higher rate of morbidity (57% vs. 41%, difference 15.5%, 95% CI 5.8-24.8,) significantly greater length of hospital stay (46 vs. 36 days, p<0.0001), greater use of high-dependency unit (0.65 vs 0.18 days, p<0.0001) and intensive-therapy unit (0.13 vs. 0.04 days, p=0.012) and thus higher costs of the procedure(23 332 vs. 17 419 £). However,t he 30-day mortality rates did not differ between the two treatment strategies (7 vs. 11 patients).
At six months the outcomes after angioplasty or surgery did not differ significantly with respect to amputation-frees urvival (48 vs. 60 patients, unadjusted hazardr atio 0.75, 95% CI 0.51-1.1, adjusted hazardr atio 0.73, 0.49-1.07), all-cause mortality (48 vs. 61 patients, unadjusted hazardratio 0.78, 95% CI 0.53-1.13, adjusted hazardr atio 0.81, 0.55-1. 19 ) and quality of life (p =0.35).
In the long term, after two years from randomisation, surgery was associated with as ignificantly reduced hazardr atio in amputation-free survival (adjusted hazardr atio 0.37, 95% CI 0.17-0.77) and allcause mortality (0.34, 95%CI 0.17-0.71, p=0.004).
the authors concluded, that patients who aree xpected to live for less than 1-2 years and have significant comorbidityshould probably,when possible, be offered angioplasty first. By contrast, in patients expected to live morethan two years and who arerelatively fit, the apparent improved durability and reintervention rate of surgery could outweigh the shortterm considerations of increased morbidity and cost.
DISCUSSIon
Institutional reports have shown excellent clinical patient outcomea fteri nfrainguinal angioplasty in CLI patients,but maybemisleading in the evaluation of the impact of treatment in the population, as the analysis is skewed by selection bias in referral centres. the comparisonbetween endovascular and surgical series seems to be skewed by dissimilarity of the groups treated. this is illustrated by the different patency and leg salvage gaps in surgical and endovascular series (16, 18, 25, 26, 29, (41) (42) (43) (44) (45) (46) (47) (48) . It is unclear whether these data suggest different severity of ischaemia treated or only that the revascularisation is needed to stay open for the period of ulcer healing.
the Cochrane database, which in other cases provide useful, formal information did not give much of help in the present issue. the two trials accepted in the Cochrane database represent an early attempt to do randomised comparison between surgery and angioplasty (38, 39) .B oth studies arer ather small and include also claudicants and arel imited to femoropopliteal and proximal lesions. the crucial information from these studies is the great heterogeneity of the lesions among CLI patients and thus relatively small number of eligible patients to randomised trials. this strongly decreases the generalizability of the results.
Beforet he BASILt rial, all previous studies that have attempted to comparesurgery and angioplasty for various degrees of lower limb ischaemia had one or morem ajor methodological problems (36) (37) (38) (39) , which have been to some extent solved in the study design of the BASIL trial. one of the major concerns has been the comparability of the lesions treated. Authors of the BASILt rial reported that the extent of lesions that had been bypassed at surgery and recanalised by angioplasty was similar (13) . Indeed, the results of this trialare claimedtoprovide,for the first time, alevel Ievidence-based data on which to practice (49) . However, am ored efinite, objective and standardized classification of the lesions by the TASC criteriac ould be warranted ( 12) as therei sag reat difference in the results of angioplasty in thefemoral, popliteal and crural artery segments (18) . In addition, the responsible consultant vascular surgeons and interventional radiologists werea llowed to use their preferred techniques and equipment for diagnosis and treatment (13) . thereforep atient selection was dependento nt echnology used and interventional skills available. Amajor problem of the BASIL trial is its poor generalizability.48% of patients with infrainguinal occlusive disease weredeemed unsuitable for revascularisation (13) and only 30% of patients undergoing revascularisation werec onsidered candidates for the trial.
It is obvious that neither mode of therapy can abolish the need for the other (38) . thus the emphasis should be which treatmentmodality to choose in any given situation. Both of these methodss hould be available at am odern vascular centrea nd the decision on the treatmentmodality should always be patient-bound taking into consideration patients´r isk factors, vein availability,l ife-time expectancy,g oals of the therapy,e xperience of the surgical and endovascular teams and the anatomy of the lesions.Current tASC document summarizes that the initial treatmentoftype Aand Bfemoropopliteal lesions is generally endovascular,t he treatment of type Cl esions can be endovascular or surgical and the treatment of type Dl esions is generally surgical (tASC 2006, in press). According to the document, in the infrapopliteal region angioplasty of ashort tibial artery stenosis can be performed but therei sn oe vidence to demonstrate either positive or negative results of the tibial angioplasty (50) .
Data from the BASIL trial, however,show the similar ability of bypass surgery and balloon angioplasty in preserving both life and limb in short term in a selectedp atient population. Thus for the first time, percutaneous angioplasty is formally validated as an acceptable option for patients with severel eg ischaemia due to infrainguinal lesions (13, 49) . these results, however,are not applicable for the majority of the patients due to problems related to the eligibility of the trial. rEFErEnCES 0 1. group tg: Epidemiology of lower extremity amputation in centres in Europe, north America and East Asia. the global
